Catalyst Wire Dossier Catalyst Wire Dossier

TR399

· Tritech Biopharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TR399, covering 2017-11-22 to 2017-11-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients [Phase 1, Phase 2]

See pricing